跳至主要内容
临床试验/NCT01172301
NCT01172301已完成不适用

Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis

Texas A&M University2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2008年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
14
试验地点
2
主要终点
Net whole body protein synthesis rate

研究概览

简要总结

Malnutrition, including muscle wasting commonly occurs in children with cystic fibrosis (CF), negatively influencing their quality of life and survival. At the time of a diagnosis of CF, severe protein deficits can already be present. It is important to get CF children fed adequately to prevent that their condition becomes worse or that recovery takes longer. Oral supplementation trials showed that gains in lean body mass are difficult to achieve in CF unless specific metabolic abnormalities are targeted. However, the specific needs for certain food components are not clear yet in children that are ill. Therefore, more information is necessary on the need for protein and certain amino acids in children with CF. Previous studies support the concept of essential amino acids (EAA) as an anabolic stimulus in the young and elderly and in insulin resistant states. Until yet no information is present on the anabolic effects of EAA in CF.

It is therefore our hypothesis that a high-leucine essential amino acids mixture specifically designed to stimulate protein anabolism will target the metabolic alterations of pediatric subjects with CF. In the present proposal, the acute metabolic effects of this high leucine essential amino acids mixture will be examined in pediatric subjects with CF and compared to that of a regular balanced total mixture of essential and non-essential amino acids. The principal endpoints will be the extent of stimulation of whole body protein synthesis as this is the principal mechanism by which either amino acid or protein intake causes muscle anabolism, and the reduction in endogenous protein breakdown. Both endpoints will be assessed by isotope methodology which is thought to be the reference method.

详细描述

In this study, we will test the following hypothesis: A high-leucine essential amino acid mixture (dose of 6.7 g) will stimulate protein anabolism to a greater extent than a standard balanced mixture of total (essential and non-essential) amino acids in CF pediatric subjects. The principal endpoints will be the extent of stimulation of protein synthesis rate and the reduction in endogenous protein breakdown. The current project will provide information that will enable us to better understand the underlying metabolic mechanisms that regulate protein metabolism in pediatric subjects with CF.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
盲法
Double (Participant, Investigator)

入排标准

年龄范围
10 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who already have a diagnosis of CF based on universal diagnostic criteria.
  • Age 14 to 21 years at the time of enrollment
  • Under routine medical control at the CF center of ACH
  • Admitted to the ACH for treatment of pulmonary exacerbation of CF disease.
  • Improvement in lung function (FEV1) at the time of enrollment back to baseline values (as determined in the clinically stable pre-hospital period)
  • Central or peripheral venous line in place
  • No planned major changes or interventions in the treatment and care of the pediatric subject on Day -2 and -1 before discharge from the hospital.

排除标准

  • Established diagnosis of Diabetes Mellitus
  • Presence of fever within the last 3 days
  • Unstable metabolic diseases including liver (cirrhosis) or renal disease
  • Chronic respiratory failure with cor pulmonale
  • Use of long-term oral corticosteroids or short course of oral corticosteroids in the preceding month before enrollment
  • Any other condition according to the principle investigator or study physician would interfere with collecting study samples
  • Failure to give assent / informed consent

结局指标

主要结局

Net whole body protein synthesis rate

时间窗: Up to 2 years

Acute change from postabsorptive state after intake of essential amino acid + LEU vs total amino acid supplement

次要结局

  • Fat-free mass(Up to 2 years)
  • Arginine turnover rate(Up to 2 years)
  • Insulin kinetics(Up to 2 years)
  • Whole body collagen breakdown rate(Up to 2 years)
  • Resting Energy expenditure(Up to 2 years)
  • Glucose kinetics(Up to 2 years)
  • Urea turnover rate(Up to 2 years)
  • Liver protein synthesis rate(Up to 2 years)
  • Amino acid kinetics(Up to 2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marielle PKJ Engelen, PhD

PhD

Texas A&M University

研究点 (2)

Loading locations...

相似试验